Subheading 3003.42 · Section VI
Medicaments; containing alkaloids or their derivatives, containing pseudoephedrine (INN) or its salts, for therapeutic or prophylactic uses, (not packaged for retail sale)
No exports were recorded in 2025. Earlier years are below.
Five-year trend
India's share of each market's imports of 3003, and who else sells there.
| Market | Its imports | India's share |
|---|---|---|
Iraq 2024
| 1.92 bn | 8.3%3rd |
Brazil 2025
| 183 mn | 43%1st |
Hungary 2025
| 205 mn | 35%1st |
United States 2025
| 2.47 bn | 2.4%7th |
Belgium 2025
| 4.80 bn | 0.7%4th |
Nigeria 2025
| 37.3 mn | 84%1st |
Mexico 2025
| 81.9 mn | 37%2nd |
Argentina 2025
| 62.1 mn | 36%2nd |
Colombia 2025
| 56.4 mn | 36%2nd |
Turkey 2025
| 122 mn | 16%4th |
The markets that buy the most 3003 where India has under 5%: openings, or where others are stronger.
| Market | Its imports | India's share |
|---|---|---|
Belgium 2025
| 4.80 bn | 0.7%4th |
Saudi Arabia 2025
| 2.93 bn | 0.7%16th |
United States 2025
| 2.47 bn | 2.4%7th |
Germany 2025
| 1.42 bn | 0.9%11th |
Ireland 2025
| 857 mn | 0.2%13th |
Netherlands 2025
| 807 mn | 0.3%16th |
China 2025
| 546 mn | <0.1%14th |
Spain 2025
| 545 mn | 2.8%10th |
Italy 2025
| 538 mn | 3.1%11th |
Canada 2025
| 490 mn | 1.1%8th |
US$ million. Each market's own import figures as reported to UN Comtrade (the year shown; some countries report late), so they differ from India's export figures above. Open a market for its six biggest suppliers. Exportsmitra's figures, not ECGC's.
Source: Harmonized System 2022 edition (World Customs Organization), from the UN Comtrade classification list.